These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4130075)

  • 21. Cell mediated lympholysis in man. The impact of SD determinants on in vitro induced lympholysis.
    Grunnet N; Kristensen T; Jorgensen F; Kissmeyer-Nielsen F
    Tissue Antigens; 1974; 4(3):218-28. PubMed ID: 4277393
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell-mediated lympholysis in man: identification of a common target determinant associated with HLA-B12 and Bw35.
    Schendel DJ; Wank R; Hansen JA; Dupont B
    Transplant Proc; 1977 Dec; 9(4):1777-80. PubMed ID: 74883
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulation of cell-mediated lympholysis by alloantisera.
    Cordier G; Betuel H; Revillard JP
    Transplant Proc; 1973 Dec; 5(4):1855-7. PubMed ID: 4272833
    [No Abstract]   [Full Text] [Related]  

  • 26. The serologically-defined (SD) private and public specificities and their genetic control of T cell mediated cytotoxicity: a discussion [proceedings].
    Peck AB; Lindahl KF
    Folia Biol (Praha); 1976; 22(6):419-21. PubMed ID: 63394
    [No Abstract]   [Full Text] [Related]  

  • 27. Donor specific cell-mediated lympholysis (CML) by peripheral blood lymphocytes (PBL) from recipients with long-term renal grafts.
    Imai T; Takasaki E; Beck Y; Inoue S; Tseng CC; Sugimoto H; Nagao T; Akiyama N; Uchida H
    Transplant Proc; 1992 Aug; 24(4):1424-6. PubMed ID: 1386698
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic control of cell-mediated lympholysis in mouse.
    Schendel DJ; Bach FH
    J Exp Med; 1974 Dec; 140(6):1534-46. PubMed ID: 4139231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of cell-mediated lympholysis (CML) determinants: potential for CML typing.
    Long MA; Yunis EJ
    Transplant Proc; 1977 Mar; 9(1):455-7. PubMed ID: 68583
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell mediated lympholysis in man. Occurrence of unexpected, HL-A (LA and FOUR) irrelevant lympholysis.
    Kristensen T; Grunnet N; Kissmeyer-Nielsen F
    Tissue Antigens; 1974; 4(4):378-82. PubMed ID: 4137565
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell-mediated lympholysis in the dog.
    Schroeder ML; Warren RP; Storb R; Goselink H; Johnson S; Brewer M
    Transplant Proc; 1975 Sep; 7(3):411-3. PubMed ID: 51526
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 33. Proliferating helper-cell (PHC) test: a possible addition to the armamentarium for histocompatibility testing.
    Bach ML; Bach FH
    Transplant Proc; 1973 Dec; 5(4):1755-7. PubMed ID: 4272830
    [No Abstract]   [Full Text] [Related]  

  • 34. MLC and CMC reactivity and specificity of idiotype-specific lymphoid cells enriched for histocompatibility (H-2) antigens.
    Folks TM; Ahmed A; Ryan JJ; Feldmann M; Woody J; Sell KW
    Transplant Proc; 1979 Mar; 11(1):683-9. PubMed ID: 88095
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated lympholysis. Importance of serologically defined H-2 regions.
    Alter BJ; Schendel DJ; Bach ML; Bach FH; Klein J; Stimpfling JH
    J Exp Med; 1973 May; 137(5):1303-9. PubMed ID: 4267208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific lymphoblastoid cell lines: possible methods for establishment and potential application in systems of delayed hypersensitivity.
    Sondel PM; Bach FH
    Birth Defects Orig Artic Ser; 1973 Jan; 9(1):98-110. PubMed ID: 4120147
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis and biological properties of products of the third SD (AJ) locus of the HL-A region.
    Mayr WR; Bernoco D; De Marchi M; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1581-93. PubMed ID: 4130068
    [No Abstract]   [Full Text] [Related]  

  • 39. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
    Bach ML; Bach FH; Zoschke DC
    Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
    [No Abstract]   [Full Text] [Related]  

  • 40. The major histocompatibility complex of rhesus monkeys. IV. Serologic identification of several new antigens of both series of RhL-A.
    Balner H; van Vreeswijk W; de Groot ML; D'Amaro J
    Transplant Proc; 1974 Jun; 6(2):111-7. PubMed ID: 4133970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.